98%
921
2 minutes
20
Background: Sepsis patients often have immune dysfunction and malnutrition, which is a high-risk disease for death in critically ill patients. Although various biomarkers can predict the prognosis of sepsis patients, they are cumbersome to implement clinically. This study evaluates the prognostic potential of the Prognostic Nutritional Index (PNI) to fill this gap.
Methods: We conducted a retrospective analysis of data from patients admitted to the Intensive Care Unit (ICU) of Beth Israel Deaconess Medical Center with sepsis between 2008 and 2022. The Prognostic Nutritional Index (PNI) was calculated using the first measurement within 24 h of admission. Kaplan-Meier analysis was used to compare mortality risks among three groups, and a multivariable Cox proportional hazards regression model assessed the link between PNI and mortality risk in sepsis patients. Restricted cubic splines (RCS) explored the potential dose-response relationship between PNI and mortality, and threshold analysis determined the critical threshold of PNI. Receiver operating characteristic (ROC) analysis evaluated the predictive ability, sensitivity, and specificity of LAR for all-cause mortality in patients with liver cirrhosis and sepsis, and calculated the area under the curve (AUC). Finally, subgroup analyses were performed to evaluate the relationship between PNI and prognosis in different populations.
Results: A total of 6,234 patients were included Kaplan-Meier analysis showed that patients with high PNI had lower 14, 28, and 90-day all-cause mortality risks (all log-rank < 0.001). The multivariable Cox proportional hazards model indicated that high PNI was independently associated with 14, 28, and 90-day all-cause mortality, with HRs of 0.62, 0.56, and 0.59 (all < 0.0001), before and after adjusting for confounders RCS analysis revealed a non-linear link between PNI and short-and medium-term all-cause mortality in sepsis patients. A two-segment Cox proportional hazards model identified inflection points at 11.6 for 14-day, 11.2 for 28-day, and 11.2 for 90-day all-cause mortality ROC analysis showed PNI has lower predictive value for sepsis prognosis than sequential organ failure assessment and acute physiology and chronic health evaluation, yet it can enhance their predictive power Subgroup analyses found no significant interaction between PNI and specific subgroups.
Conclusion: There is a significant association between short-term and medium-term all-cause mortality in sepsis patients and PNI, indicating that PNI can be a valuable indicator for predicting in-hospital and ICU mortality risk.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12259434 | PMC |
http://dx.doi.org/10.3389/fnut.2025.1600943 | DOI Listing |
JAMA Netw Open
September 2025
Social and Behavioral Sciences Branch, Division of Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland.
Importance: Higher intellectual abilities have been associated with lower mortality risk in several longitudinal cohort studies. However, these studies did not fully account for early life contextual factors or test whether the beneficial associations between higher neurocognitive functioning and mortality extend to children exposed to early adversity.
Objective: To explore how the associations of child neurocognition with mortality changed according to the patterns of adversity children experienced.
Hormones (Athens)
September 2025
Division of Endocrinology, Baltimore VA Medical Center, Baltimore, MD, USA.
Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are a fairly new class of agents for diabetes that have demonstrated significant benefits in glycemic control and cardiovascular outcomes with outpatient use. The aim of this review is to provide an overview of the effect of SGLT2i use on glycemic control and clinical outcomes in the hospital setting.An electronic search of PubMed was conducted to analyze publications that assessed the inpatient use of SGLT2i and included patients with diabetes.
View Article and Find Full Text PDFJ Am Geriatr Soc
September 2025
Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA.
Background: In the National Health and Aging Trends Study (NHATS), use of its Sensitive files leads to incomplete ascertainment of mortality, largely because of losses to follow-up. To account for these losses, we compared two censoring approaches for evaluating mortality.
Methods: In a hybrid approach, most participants were censored at the time of last contact, while the remainder were censored at the time of last completed interview.
Jpn J Clin Oncol
September 2025
International Health Program, National Yang Ming Chiao Tung University, No. 155, Sec. 2, Linong St., Beitou Dist., Taipei City 112, Taipei, Taiwan.
Objectives: Treatment delay can adversely affect cancer prognosis and public health. However, previous studies have not examined the association between cancer treatment delay and 5-year mortality risk for various cancer types in a single study population.
Methods: We used retrospective cohort data from 21 740 patients diagnosed with common cancers between 2000 and 2017, with mortality follow-up to 2022, from the Philippines' Department of Health-Rizal Cancer Registry to understand how treatment delay of <30, 30-90, or >90 days was associated with 5-year all-cause mortality risk, by cancer type and stage at diagnosis.
Int J Surg
September 2025
Department of Cardiovascular Surgery, The Affiliated Hospital, Southwest Medical University, Metabolic Vascular Diseases Key Laboratory of Sichuan Province, Key Laboratory of Cardiovascular Remodeling and Dysfunction, Luzhou, Sichuan, PR China.
Objective: This meta-analysis aimed to compare the perioperative safety and efficacy of transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in bicuspid aortic valve (BAV) stenosis.
Methods: We systematically analyzed studies from PubMed, Cochrane Library, Embase, and CNKI comparing TAVR and SAVR in BAV stenosis. Outcomes included postoperative mortality, complications, all-cause survival, and freedom from stroke.